Inner Spirit Holdings Announces Closing of $9.3 Million Convertible Debenture Financing
CALGARY , May 24, 2019 /CNW/ - Inner Spirit Holdings Ltd. ("Inner Spirit" or the "Company") (ISH.CN) today announced it has closed its previously announced offering (the "Offering") of secured convertible...
Veggie Meat and Marijuana: The Hype (Cycle) Is Real
Cannabis and plant-based meat substitutes have real long-term potential, but keep a cool head.
Stocks To Buy: Is It Time To Buy Or Sell These Large-Cap Stocks?
Looking for stocks to buy? Get analysis of large-cap stocks like Amazon, Alibaba and Dow Jones stocks GE and Microsoft to see if it's time to buy — or sell.
11 Pot Stocks Now Listed on the NYSE or Nasdaq
Nearly a dozen marijuana stocks are now listed side by side with time-tested businesses on reputable U.S. exchanges.
4 Billion-Dollar Marijuana Stocks With Rising Profit Estimates
Despite weaker-than-expected cannabis sales in Canada, some big pot stocks have increasing EPS projections.
Is Tilray Stock A Buy Right Now? Here's What Earnings, Charts Show
Tilray was 2018's best-performing stock amid a stampede into marijuana stocks, and it got a bump early in May after its quarterly sales beat estimates.
Tilray Boosts Export Capability With EU Manufacturing License, GMP Certification
Tilray, Inc. (NASDAQ: TLRY) announced Thursday that its wholly owned subsidiary Tilray Portugal Unipessoal Lda. received a standard manufacturing license for its Cantanhede, Portugal-based Biocant Park...
Tilray's Portugal sub receives GMP certification for export of dried cannabis
Tilray Inc. said its Portugal-based wholly-owned subsidiary, Tilray Portugal Unipessoal Lda. has received a Good Manufacturing Practices (GMP) certification and a standard manufacturing license, which...
Tilray® Boosts International Export Capacity with Manufacturing License and GMP Certification at EU Campus
Tilray, Inc. (“Tilray” or “the Company”) (TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced that its wholly-owned subsidiary Tilray Portugal Unipessoal...
Tetra Bio-Pharma: Diamond In The Rough
Editor's note: Seeking Alpha is proud to welcome James Mase as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also...
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. was incorporated in 2018 and is headquartered in Nanaimo, Canada.
A proud pioneer, we are the first GMP-certified medical cannabis producer to supply cannabis flower and extract products to tens of thousands of patients, physicians, pharmacies, hospitals, governments and researchers on five continents.
Tilray's experience is unmatched worldwide. Our team professionals on the ground in 7 countries serves thousands of patients around the globe. Our flagship cultivation facility is among the most advanced in the world.
Tilray is the first GMP-certified medical cannabis producer to supply cannabis flower and extracts. All of our products are produced with meticulous care to ensure the highest quality, consistency and purity for our patients.
We are committed to scientific research that leads to an improved quality of life for patients in a time frame that matters. We partner with leading hospitals and universities to advance the clinical applications of cannabinoids.
Tilray takes tremendous pride in our customer service, patient outreach, and physician interaction. We recognize the importance of tracking potential adverse events as well as therapeutic benefits in order to ensure the safety of our patients.